CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$346,112
-64.9%
136,803
-7.7%
0.00%
Q2 2023$986,839
-63.2%
148,174
+3.0%
0.00%
-100.0%
Q1 2023$2,685,043
-12.8%
143,893
+0.4%
0.00%0.0%
Q4 2022$3,077,697
+85.3%
143,282
+2.0%
0.00%0.0%
Q3 2022$1,661,000
+0.5%
140,493
+12.3%
0.00%0.0%
Q2 2022$1,652,000
-41.6%
125,139
-7.5%
0.00%0.0%
Q1 2022$2,830,000
+5.7%
135,310
+2.7%
0.00%0.0%
Q4 2021$2,678,000
-32.1%
131,708
+1.3%
0.00%0.0%
Q3 2021$3,945,000
+32.1%
129,964
+26.5%
0.00%0.0%
Q2 2021$2,986,000
-28.0%
102,744
+7.0%
0.00%
-50.0%
Q1 2021$4,145,000
-4.2%
96,021
+2.6%
0.00%0.0%
Q4 2020$4,326,000
+9.8%
93,618
+3.0%
0.00%0.0%
Q3 2020$3,941,000
+181.3%
90,875
+243.9%
0.00%
+100.0%
Q2 2020$1,401,000
+310.9%
26,422
+73.5%
0.00%
Q1 2020$341,000
+54.3%
15,232
+0.9%
0.00%
Q4 2019$221,000
+148.3%
15,092
+20.4%
0.00%
Q3 2019$89,000
-35.5%
12,5360.0%0.00%
Q2 2019$138,00012,5360.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders